Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported annual fiscal-period values; no daily interpolation.
PEG RATIO
N/A
PEG RATIO AVG TTM
0.05
PEG RATIO AVG 3Y
0.46
PEG RATIO AVG 5Y
0.38
PEG RATIO AVG 10Y
N/A
PEG RATIO AVG 15Y
N/A
PEG RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
PDS Biotechnology Corporation
Market Cap
$11.79M
PEG Ratio
N/A
TTM Avg
0.05
3Y Avg
0.46
5Y Avg
0.38
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PDS Biotechnology Corporation (PDSB) | $11.79M | N/A | 0.05 | 0.46 | 0.38 |
| Shoulder Innovations, Inc. (SI)vs › | $438.82M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $492.43M | N/A | 2.52 | 3.04 | 2.90 |
| Teladoc Health, Inc. (TDOC)vs › | $1.18B | N/A | 0.08 | 0.12 | 0.31 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.23B | N/A | 0.12 | 0.27 | 0.46 |
| TransMedics Group, Inc. (TMDX)vs › | $3.06B | 0.05 | 0.05 | 1.65 | 1.32 |
| Doximity, Inc. (DOCS)vs › | $5.00B | 0.58 | 0.96 | 0.67 | 1.38 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.40B | 8.41 | 5.09 | 3.27 | 2.83 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.43B | N/A | 0.84 | 0.69 | 0.69 |
| Chemed Corporation (CHE)vs › | $6.84B | N/A | 3.14 | 3.14 | 2.77 |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2025-12-31 | 0.04 |
| 2024-12-31 | 0.06 |
| 2023-12-31 | 1.28 |
| 2021-12-31 | 0.47 |
| 2020-12-31 | 0.06 |
| 2019-12-31 | 0.02 |
| 2018-12-31 | 0.01 |
